Amgen Inc vs. ImmunityBio, Inc. Common Stock
Amgen Inc and ImmunityBio, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| AMGN | IBRX | |
|---|---|---|
| Market Cap | $220.18 billion | $10.90 billion |
AMGN leads on 1 of 1 size & scale factors.
Dividend
| AMGN | IBRX | |
|---|---|---|
| Dividend Yield | 2.48% | — |
AMGN and IBRX split the dividend factors evenly.
Risk & Sentiment
| AMGN | IBRX | |
|---|---|---|
| Short Interest | 1.66% | 0.42% |
IBRX leads on 1 of 1 risk & sentiment factors.
Dig deeper: AMGN overview, AMGN financials, IBRX overview, IBRX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
